Anheuser-Busch InBev stock draws fresh analyst support. Jefferies and JPMorgan lift the valuation bar

Anheuser-Busch InBev stock sees multiple Buy calls as Jefferies raises its target to EUR 84 and JPMorgan reiterates an Overweight view, underscoring a supportive analyst consensus around the brewer's earnings trajectory.

By Thomas Clarke, Operations & Strategy desk. Reviewed on June 30, 2026 at 2:34 p.m. ET.

Anheuser-Busch InBev SA/NV (ISIN BE0974293251) is trading under renewed analyst scrutiny as several major brokers reaffirm constructive views on the brewer, highlighting earnings resilience and the importance of its global brand portfolio for long-term cash generation. Fresh research updates reported on June 30, 2026 show Jefferies and JPMorgan maintaining positive stances while refining their valuation frameworks for the stock.

Jefferies lifts target to EUR 84

According to a Jefferies research update reported by MarketScreener, analyst Edward Mundy has reiterated a Buy rating on Anheuser-Busch InBev and increased the price target from EUR 80 to EUR 84, signaling greater confidence in the brewer's ability to improve its financial position ahead of the upcoming half-year report. The note, published on June 30, 2026 at 1:26 a.m. EDT, describes a better operating backdrop at AB InBev, with the analyst pointing to an improving situation at the brewing group as the basis for the revised target level.

A separate coverage item from aktiencheck.de echoes the Jefferies move, noting that the target for AB Inbev was raised from EUR 80 to EUR 84 while the Buy recommendation was maintained. In this German-language summary, the analyst highlights that conditions for the brewing group are improving, and the research comment is framed as an outlook ahead of the half-year results, which investors will be watching for confirmation of the margin trajectory and leverage reduction plans.

Jefferies' updated target sits above the current trading band, with MarketScreener data showing a last close price of around $83.97 in USD terms and an average analyst target near $91.42 when converted from the broader coverage universe. This differential between spot pricing and the consensus valuation range provides a numerical backdrop for investors assessing upside potential against execution risks in areas such as cost management, premiumization and geographic mix.

JPMorgan reaffirms Overweight stance

In parallel to the Jefferies move, a JPMorgan research call summarized by MarketScreener indicates that the US bank remains positive on AB Inbev, reaffirming a Buy-oriented stance with a target price of EUR 79.88. The item, also dated June 30, 2026, shows JPMorgan keeping its rating unchanged while the broker continues to position AB Inbev as an Overweight holding in its coverage universe, reflecting ongoing conviction in the group's earnings and cash flow profile.

A German summary on aktiencheck.de reinforces the view that JPMorgan has left AB Inbev at an Overweight rating with the EUR 79.88 target, underscoring that the bank still sees upside from current levels. Price data in that piece show the stock around EUR 73.58 on June 30, 2026 at 7:43 a.m., translating into a modest implied gap between the trading price and the bank's valuation reference, which investors can quantify as part of their risk-reward work on the brewer.

The clustering of Buy-oriented ratings from large brokers such as Jefferies and JPMorgan contributes to a supportive analyst consensus picture for AB Inbev. MarketScreener's overview of the coverage set points to a mean recommendation of Buy from around 25 analysts, with the aggregated average price target of about $91.42 supporting a narrative of expected value creation over the medium term. For market participants, this consensus backdrop provides context for daily price moves and for any upcoming guidance changes around margins, debt reduction and capital returns.

Global operations and earnings outlook

Anheuser-Busch InBev operates as one of the world's largest brewing groups, with a portfolio that spans global, regional and local brands across developed and emerging markets. Coverage summaries such as the overview on ad-hoc-news.de emphasize a steady earnings calendar and a clear consensus picture as the brewer's shares trade on Euronext Brussels, with margins and cash generation identified as key drivers for the valuation story.

The same overview notes that investors tend to benchmark AB Inbev's home-market listing on Euronext Brussels against peers when assessing valuation, reflecting the group's European base even though it generates material revenue across North America, Latin America and other regions. A related angle comes from broader market products such as the iShares MSCI Belgium Capped ETF, where Anheuser-Busch InBev appears as a major component: Robinhood data for the EWK ETF show AB Inbev accounting for more than 22 percent of the fund's assets on June 30, 2026, underscoring the brewer's importance in Belgium-linked equity exposures.

On the debt and financing side, instruments such as a high-coupon equity-linked bond referenced by onvista.de illustrate how AB Inbev shares serve as an underlying for structured products, with one notable note carrying a 24.10 percent annual coupon and maturing on December 28, 2026. Such instruments highlight how investors with different risk profiles access AB Inbev exposure beyond straightforward equity purchases, while also reminding equity holders that the stock is woven into a range of derivative and credit-linked strategies.

Zero-alcohol portfolio and Corona Cero

Beyond pure financial metrics, AB Inbev's product and brand strategy is an important part of the investment case. A recent feature on Corona Cero describes the brand as a zero-alcohol extension of the well-known Corona family, retaining the clear beach-oriented look while reducing alcohol content to 0.0 percent. The article notes that Corona Cero targets daytime and mindful drinkers, positioning itself for consumption occasions where traditional beer might not fit, and frames the product as part of AB Inbev's broader push into moderation-oriented offerings.

Under global CEO Michel Doukeris, AB Inbev has been expanding its zero-alcohol lineup, and Corona Cero is highlighted as a bestseller within that segment, suggesting that the non-alcoholic category can contribute meaningfully to the group's volumes and value. The ad-hoc-news feature explicitly connects Corona Cero to Anheuser-Busch InBev shares, stating that the product drives investor interest in the stock and fits into a narrative where moderation and choice can still support margins, particularly when such variants maintain premium branding and pricing relative to traditional offerings.

From a strategy perspective, the expansion of zero-alcohol products like Corona Cero can help AB Inbev broaden its addressable market and align with regulatory and consumer trends around health, responsible drinking and diversification of beverage portfolios. For investors, these shifts matter because they can influence mix, pricing power and ultimately profit margins across regions, especially in markets where younger consumers may favor lower-alcohol or alcohol-free options while still seeking branded experiences.

Euronext Brussels listing and recent price context

Anheuser-Busch InBev shares are listed on Euronext Brussels, and multiple coverage items across portals show the stock trading in the low to mid-70s in euros on June 30, 2026. The aktiencheck.de summaries for the Jefferies and JPMorgan notes reference prices around EUR 73.60 and EUR 73.58 in morning trading, indicating a modest positive move of around 0.2 to 0.25 percent compared with prior levels at that time of day. These snapshots give investors a useful reference point against the EUR 79.88 JPMorgan target and the EUR 84 Jefferies target when considering valuation spreads.

Additionally, MarketScreener's analyst consensus section, attached to the Jefferies and JPMorgan items, points to a last close price in USD terms of about $83.97 and an average target price near $91.42, reinforcing the idea that the broker community collectively sees scope for appreciation from recent closing levels. As of June 30, 2026, 2:34 p.m. ET, a representative price level of approximately EUR 73.60 on Euronext Brussels provides a workable benchmark for comparing AB Inbev's equity valuation to peers in the global beer and beverage sector, while acknowledging that intraday movements and currency effects can shift the numbers within a typical trading session.

Anheuser-Busch InBev key data

• Company: Anheuser-Busch InBev SA/NV
• ISIN: BE0974293251
• Ticker: ABI
• Exchange: Euronext Brussels
• Price (as of June 30, 2026, 2:34 p.m. ET): EUR 73.60
• Market cap: Data per latest market sources
• Sector / Industry: Consumer staples - Breweries
• Index membership: Included in Belgium-linked equity benchmarks such as the MSCI Belgium Capped ETF
• Next earnings date: Half-year results expected in 2026, exact date to be confirmed by the company

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.